Spotlight on Cardiovascular VC Funding In 1st Half 2006

Atrial fibrillation is the hottest sector among five highly dynamic areas within cardiovascular technology, according to an analysis by cvPipeline.

Atrial fibrillation (afib) is the hottest sector among five highly dynamic areas within cardiovascular technology, according to an analysis by cvPipeline of venture capital (VC) funding patterns in afib, heart failure, heart valves, regenerative medicine, and drug-eluting stents (DES) over the last year and a half.

The cvPipeline analysis shows that in the first half of 2006, eight afib start-ups received VC investments, and by contrast,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.

SS Innovations’ SSI Mantra 3 Poised To Challenge Da Vinci In Robotic Surgery Market

 
• By 

SS Innovations reported its first SSi Mantra 3 robotic cardiac surgery in South America as it prepares to file for US FDA de novo clearance and a CE mark. The firm aims to challenge Intuitive Surgical with a lower-cost, flexible system targeting US and European markets.

Liquid Biopsy Startup Mursla Bio Launches AI Precision Medicine Platform

 

The new AI Precision Medicine platform supports the company’s flagship product, EvoLiver, which received US FDA breakthrough device designation in April.

Prix Galien Spotlights Mental Health ‘Renaissance’ But Systemic Hurdles Persist

 

Experts at the Prix Galien UK Forum discussed the future of mental health innovation, emphasizing the important roles of digital solutions, diagnostic biomarkers and community involvement.

More from Business